Danaher (NYSE:DHR) said it lured Brian Ellis from Medtronic (NYSE:MDT) to be its new general counsel, replacing Jonathan Graham, who jumpoed ship for Amgen (NSDQ:AMGN) last May.
Ellis was general counsel for Medtronic’s restorative therapies group, after stints as GC and chief compliance officer for monitoring solutions at GE Healthcare (NYSE:GE)
“Brian brings a wealth of experience leading and developing global legal teams and supporting business growth. I am confident that Brian’s background and experience position him to be a major contributor at Danaher,” president & CEO Thomas Joyce Jr. said in prepared remarks.
Akers Biosciences’ new CEO is BD vet Gormally
Akers Biosciences said it tapped Becton Dickinson & Co. (NYSE:BDX) veteran John Gormally to be its new CEO.
Read more
Uluru (OTC:ULUR) said president & CEO Kerry Gray resigned Nov. 20 and was replaced on an interim basis by board member Helmut Kerschbaumer.
Read more
Alphatec (NSDQ:ATEC) said senior vice president of international Mark Bullivant resigned Nov. 13, with his duties to be assumed by other executives at the company.
Read more
Tandem Diabetes Care (NSDQ:TNDM) said its chief commercial officer, Robert Anacone, plans to retire effective Dec. 31.
Read more